SGIOY:OTCMKTS
Shionogi 2 ADR Representing 1 Ord Shs
US$Â 9.20
arrow_upward
+0.74%(+0.068) Siku 1
16 Okt, 14:41:12 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya SGIOY...
Fungua
US$Â 9.36
Juu
US$Â 9.36
Chini
US$Â 9.19
Mtaji wa soko
2.61T
Wastani wa kiasi cha mauzo
elfu 175.16
Kiasi cha mauzo ya hisa
elfu 123.04
Juu kwa wiki 52
US$Â 12.00
Chini kwa wiki 52
US$Â 7.83
Beta
0.07
Hisa za wawekezaji
1.78B
Idadi ya wafanyakazi
elfu 6
Fungua
US$Â 9.36
Juu
US$Â 9.36
Chini
US$Â 9.19
Mtaji wa soko
2.61T
Wastani wa kiasi cha mauzo
elfu 175.16
Kiasi cha mauzo ya hisa
elfu 123.04
Juu kwa wiki 52
US$Â 12.00
Chini kwa wiki 52
US$Â 7.83
Beta
0.07
Hisa za wawekezaji
1.78B
Idadi ya wafanyakazi
elfu 6
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 23 zilizopita
Jefferies sets JPY 3,900.00 target for Shionogi stock
Wasifu
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana.
Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.
In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.
Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV.
The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index.
In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m.
On 5 October 2026, Shionogi announced an agreement to acquire IntraBio for US$2 billion through its US subsidiary, Shionogi Inc. Wikipedia
Kuhusu Shionogi 2 ADR Representing 1 Ord Shs
Afisa Mkuu Mtendaji (CEO)Isao Teshirogi
Wafanyakazielfu 6.22
Lilianzishwa1878
Makao makuu-
Sekta-
Tovutishionogi.com